PFM
Privium Fund Management Portfolio holdings
AUM
$543M
1-Year Est. Return
99.51%
This Fund
S&P 500
1 Year Est. Return
+99.51%
AUM
$543M
AUM Growth
-$13.1M
(-2.4%)
Holding
65
Top Buys
| 1 | +$7.74M | |
| 2 | +$6.94M | |
| 3 | +$4.76M | |
| 4 |
Biogen
BIIB
|
+$3.52M |
| 5 |
enGene Holdings
ENGN
|
+$2.82M |
Top Sells
| 1 | +$16.9M | |
| 2 | +$6.87M | |
| 3 | +$6.41M | |
| 4 |
Arrowhead Research
ARWR
|
+$3.71M |
| 5 |
Sea Limited
SE
|
+$3.26M |
Sector Composition
| 1 | Healthcare | 29.46% |
| 2 | Consumer Discretionary | 27.3% |
| 3 | Technology | 25.78% |
| 4 | Financials | 8.49% |
| 5 | Communication Services | 7.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
enGene Holdings
ENGN
$677M
| $3.18M | 0.59% |
+352,087
|
|
||
27
BioNTech
BNTX
$27.7B
| $3.17M | 0.58% |
33,300
+14,300
|
|
||
28
Krystal Biotech
KRYS
$8.06B
| $3M | 0.55% |
12,170
|
|
||
29
Ambev
ABEV
$49.3B
| $2.63M | 0.48% |
1,063,174
+166,040
|
|
||
30
Zai Lab
ZLAB
$2.15B
| $2.33M | 0.43% |
132,189
|
|
||
31
CRISPR Therapeutics
CRSP
$5.77B
| $2.25M | 0.41% |
42,874
+2,874
|
|
||
32
Beam Therapeutics
BEAM
$2.89B
| $1.98M | 0.36% |
71,500
+10,500
|
|
||
33
Lexeo Therapeutics
LXEO
$524M
| $1.91M | 0.35% |
192,550
+194
|
|
||
34
Stoke Therapeutics
STOK
$2.08B
| $1.75M | 0.32% |
+55,000
|
|
||
35
MeiraGTx Holdings
MGTX
$609M
| $1.59M | 0.29% |
200,000
+37,000
|
|
||
36
4D Molecular Therapeutics
FDMT
$493M
| $1.57M | 0.29% |
210,000
+12,542
|
|
||
37
SLB Ltd
SLB
$76.8B
| $1.49M | 0.27% |
38,805
+19,108
|
|
||
38
Moderna
MRNA
$20.9B
| $1.46M | 0.27% |
49,594
+2,594
|
|
||
39
Hims & Hers Health
HIMS
$3.31B
| $1.3M | 0.24% |
40,000
|
|
||
40
Cartesian Therapeutics
RNAC
$197M
| $1.24M | 0.23% |
+172,500
|
|
||
|
VZLA
41
Vizsla Silver
VZLA
$1.51B
| $1.12M | 0.21% |
204,654
|
|
||
42
Pfizer
PFE
$157B
| $940K | 0.17% |
37,750
|
|
||
43
Sarepta Therapeutics
SRPT
$1.76B
| $925K | 0.17% |
+43,000
|
|
||
44
Taysha Gene Therapies
TSHA
$1.24B
| $907K | 0.17% |
164,900
+30,000
|
|
||
45
NOV
NOV
$7.3B
| $830K | 0.15% |
53,126
-10,750
|
|
||
|
SA
46
Seabridge Gold
SA
$4.19B
| $703K | 0.13% |
23,756
-24,718
|
|
||
|
AUTL
47
Autolus Therapeutics
AUTL
$455M
| $649K | 0.12% |
326,245
+17,408
|
|
||
48
Rocket Pharmaceuticals
RCKT
$542M
| $597K | 0.11% |
170,146
-262,614
|
|
||
49
Transocean
RIG
$7.14B
| $577K | 0.11% |
139,604
+37,604
|
|
||
50
SandRidge Energy
SD
$645M
| $560K | 0.1% |
38,792
-11,600
|
|